Effect of donor on outcomes after myeloablative conditioning with daily IV busulfan and fludarabine (FLUBUP) +/- TBI with thymoglobulin: Transplants from mismatched unrelated donors (MMUD) have worse survival due to higher transplant-related mortality (TRM).

被引：0
|
作者：
Russell, James A. [1 ]
Kmet, Leanne [1 ]
Savoie, Mary Lynn [1 ]
Bahlis, Nizar J. [1 ]
Chaudhry, M. Ahsan [1 ]
Quinlan, Diana M. [1 ]
Geddes, Michelle [1 ]
Turner, A. Robert [1 ]
Larratt, Loree M. [1 ]
Brown, Christopher [1 ]
Storek, Jan [1 ]
Stewart, Douglas A. [1 ]
机构：
[1] Duke Univ, Med Ctr, Div Cellular Therapy, Durham, NC USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.5398.5398
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5398
引用
收藏
页码：443B / 443B
页数：1
相关论文
共 4 条
  • [1] Adult matched sibling blood cell transplants (BCT) after myeloablative conditioning incorporating daily intravenous (IV) Busulfan (BU) and low-dose antithymocyte globulin (ATG): Outcomes with particular respect to transplant-related mortality (TRM) in 140 patients.
    Russell, JA
    Chaudhy, AM
    Jeje, O
    Quinlan, D
    Stewart, D
    Morris, D
    Bahlis, NJ
    Savoie, L
    Brown, CB
    Larratt, L
    Geddes, M
    Turner, AR
    BLOOD, 2004, 104 (11) : 636A - 636A
  • [2] Hematopoietic stem cell transplantation (SCT) for hematologic malignancy from 10/10 matched unrelated donors (MUD) with a myeloablative once daily IV fludarabine (Flu)/Busulfan based regimen (FLUBUP) with thymoglobulin: Outcomes according to stem cell source.
    Russell, James A.
    Ahsan Chaudhry, M.
    Geddes, Michelle
    Bahlis, Nizar J.
    Savoie, Mary Lynn
    Larratt, Loree M.
    Quinlan, Diana M.
    Robert Turner, A.
    Balogh, Alexander
    Storek, Jan
    Brown, Christopher
    Stewart, Douglas A.
    BLOOD, 2006, 108 (11) : 896A - 896A
  • [3] Hematopoietic stem cell transplantation (SCT) for hematologic malignancy from matched related donors (MRD) with a myeloablative once daily IV busulfan (Bu)/fludarabine (Flu) based regimen (FLUBUP) with thymoglobulin: Outcomes in 200 patients with over one year follow-up.
    Russell, James A.
    Bahlis, Nizar J.
    Savoie, Mary Lynn
    Chaudhry, M. Ahsan
    Turner, A. Robert
    Larratt, Loree M.
    Quinlan, Diana M.
    Brown, Christopher
    Balogh, Alexander
    Storek, Jan
    Geddes, Michelle
    Stewart, Douglas A.
    BLOOD, 2006, 108 (11) : 853A - 854A
  • [4] MYELOABLATIVE TRANSPLANTATION FROM MATCHED SIBLINGS (MSD) USING A DAILY INTRAVENOUS BUSULFAN (BU)/FLUDARABINE (FLU) REGIMEN WITH THYMOGLOBULIN (TG): ANALYSIS INVOLVING 200 PATIENTS INDICATES LOW TRANSPLANT-RELATED MORTALITY (TRM) IN ALL BUT OLDER PATIENTS WITH HIGH-RISK DISEASE
    Russell, J.
    Duan, Q.
    Chaudhry, A.
    Brown, C.
    Bahlis, N.
    Savoie, L.
    Daly, A.
    Geddes, M.
    Storek, J.
    Balogh, A.
    Zacarias, N.
    Duggan, P.
    Quinlan, D.
    Turner, R.
    Larratt, L.
    Stewart, D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 102 - 102
1